Denison Pharmaceuticals, LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Aug 26, 2025
  • Last warning letter 2023
Inspections 9 2 OAI
Recalls 8 0 Class I (0%)
Warning letters 1 Latest Jul 26, 2023
510(k) clearances 0 None on file

Denison Pharmaceuticals, LLC has 8 FDA recalls, 9 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Denison Pharmaceuticals, LLC, the most recent on Jul 26, 2023.

What these totals cover: FDA records filed under the name "Denison Pharmaceuticals, LLC" and its spelling variant "Denison Pharmaceuticals".

Latest recall
D-0273-2025 · Class II · Feb 24, 2025
Latest inspection
Aug 26, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls8Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections9Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Denison Pharmaceuticals, LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Denison Pharmaceuticals, LLC: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (1 OAI), 1 warning letter, 4 recall records (0 Class I) 2024: 1 inspection (1 OAI), 0 warning letters, 3 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510010
202411030
202311140
202200000
202100000
202000000
201900000
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Denison Pharmaceuticals, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Denison Pharmaceuticals, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Denison Pharmaceuticals, LLC FDA Warning Letters

1 warning letter on Jul 26, 2023.

IssuedSubjectIssuing officeClose-out letter
Jul 26, 2023 · Letter on fda.gov CGMP/Finished Pharmaceuticals/AdulteratedDivision of Pharmaceutical Quality Operations I

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

8 recall records from May 3, 2023 to Feb 24, 2025.

NumberClassProductDate
D-0273-2025Class IIZapzyt, Acne Treatment Gel, 10% benzoyl peroxide Gel, packaged in 1 oz (28.35g) tube, Distributed…Feb 24, 2025
D-0033-2025Class IIIAdult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400mg), packaged…Sep 25, 2024
D-0034-2025Class IIIKids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg), packaged…Sep 25, 2024
D-0557-2024Class IILittle Remedies Gas Relief Drops (Simethicone/Antigas), packaged in 1 fl. oz. (30 mL) bottle with…May 28, 2024
D-0774-2023Class IIPin-Away PYRENTAL PAMOATE (Pyrantel base 50 mg / mL) Pinworm Treatment, 2 FL OZ (60 mL) bottle…May 3, 2023
D-0775-2023Class IISafe tussin PM, NIGHT TIME Cough Relief, (Dextromethorphan HBr, USP 7.5mg, Doxylamine Succinate…May 3, 2023
D-0772-2023Class IISafe tussin DM, DAY TIME Cough Relief, (Dextromethorphan HBr, USP 10mg Guaifenesin, USP 100mg), 4.0…May 3, 2023
D-0773-2023Class IIColic Calm, Colic, Gas & Reflux, Homeopathic Medicine, 2 Fl. Oz (59 ml) bottle. Distributed by…May 3, 2023

Recent FDA inspections

9 inspections from Aug 5, 2009 to Aug 26, 2025.

DateSiteProductClassificationFEI
Aug 26, 2025Lincoln, RIFood/CosmeticsVoluntary Action Indicated (VAI)1210580
Jul 29, 2024Lincoln, RIDrugsOfficial Action Indicated (OAI)1210580
Feb 9, 2023Lincoln, RIDrugsOfficial Action Indicated (OAI)1210580
Oct 25, 2017Lincoln, RIVeterinaryVoluntary Action Indicated (VAI)1210580
Apr 5, 2016Pawtucket, RIVeterinaryVoluntary Action Indicated (VAI)3012228456
Apr 5, 2016Lincoln, RIDrugsVoluntary Action Indicated (VAI)1210580
Mar 15, 2013Lincoln, RIVeterinaryNo Action Indicated (NAI)1210580
Oct 7, 2010Lincoln, RIDrugsNo Action Indicated (NAI)1210580
Aug 5, 2009Lincoln, RIVeterinaryVoluntary Action Indicated (VAI)1210580
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Denison Pharmaceuticals, LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jul 26, 2023.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1210580Lincoln, RI8Aug 26, 2025
FEI 3012228456Pawtucket, RI1Apr 5, 2016

Denison Pharmaceuticals, LLC and the FDA: common questions

Has Denison Pharmaceuticals, LLC received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Denison Pharmaceuticals, LLC. The most recent is dated Jul 26, 2023, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".

Has Denison Pharmaceuticals, LLC received an FDA Form 483?

FDA has not published a Form 483 for "Denison Pharmaceuticals, LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Denison Pharmaceuticals, LLC?

The most recent FDA inspection on file ended Aug 26, 2025 at Lincoln, RI and was classified VAI. FDA has 9 inspections of Denison Pharmaceuticals, LLC on file, 2 of them classified OAI (official action indicated).

Has Denison Pharmaceuticals, LLC had an FDA recall?

Yes. Denison Pharmaceuticals, LLC has 8 FDA recalls on record. The most recent started Feb 24, 2025.

Need more than this page shows? Ask about Denison Pharmaceuticals, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.